Cumulative incidence of CNS relapse in patients with ENKTL by S-ID-MTX and CNS-PINK risk groups. Frequency in the training cohort (A-B) and the validation cohort (C-D). S-ID-MTX, SMILE or SMILE-like regimens with intermediate-dose MTX.